On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Moderna (NasdaqGS:MRNA) experienced a 10% share price increase, coinciding with broader market gains but slightly below the Nasdaq Composite's 5% rise. Despite the market being uplifted by strong ...

Personalized mRNA vaccines are customized to each patient's specific tumor ... Another significant trend is the integration of artificial intelligence (AI) and machine learning (ML) in cancer antigen ...

mRNA vaccines offer clear advantages and disadvantages ... candidates for seasonal influenza and COVID-19 in Phase 2 and avian influenza in Phase 1 clinical development. Sanofi is developing ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The H5N1 avian influenza virus, first detected in humans ... with the U.S. allocating 500 million USD to pharmaceutical companies for mRNA-based vaccine development. Lessons from the COVID-19 ...

The H5N1 avian influenza virus, first detected in humans ... with the U.S. allocating 500 million USD to pharmaceutical companies for mRNA-based vaccine development. Lessons from the COVID-19 ...

With some mRNA approaches also using AI to personalise each vaccine to the patient, there are also questions about how to regulate a product that can differ each time it is delivered. As such ...

For decades, expanding into foreign markets meant making a major investment in physical presence – setting up local offices ...